Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat

Pharmaceutical Research

Volumn 15, Issue 11, 1998, Pages 1767-1774

  Hajri, Amor ^a   Damgé, Christiane ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Affinity binding sites; Cholecystokinin; Cholecystokinin antagonist; Exocrine pancreas; Pancreatic cancer

Indexed keywords

AMYLASE; APROTININ; ASCORBIC ACID; AZASERINE; BENZYLSULFONYL FLUORIDE; BOVINE SERUM ALBUMIN; CARBACHOL; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; DEXAMETHASONE; EGTAZIC ACID; EPIDERMAL GROWTH FACTOR; ISOBUTYLMETHYLXANTHINE; LEUPEPTIN; LORGLUMIDE; RNA; SELENIUM; SOYBEAN TRYPSIN INHIBITOR; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; MALE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; TUMOR VOLUME;

ANIMALS; AZASERINE; CARCINOMA, ACINAR CELL; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; IODINE RADIOISOTOPES; PANCREATIC NEOPLASMS; RADIOLIGAND ASSAY; RATS; RATS, INBRED LEW; RECEPTORS, CHOLECYSTOKININ; SINCALIDE; TUMOR CELLS, CULTURED;

EID: 0031758829     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011973015634     Document Type: Article

References (32)

1. A. Hajri, M. Aprahamian, and C. Damgé. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat. Regul. Pept. 43:66-72 (1989).
2. L. Karsenty, A. Hajri, M. Aprahamian, J. C. Garaud, M. Doffoël, and C. Damgé. Inhibition of growth of transplanted rat pancreatic acinar carcinoma with CCK-8. Pancreas 8:204-211 (1993).
3. M. Meijers, A. van Garderen-Hoetmer, C. B. Lamers, L. C. Rovati, J. B. Jansen, and R. A. Woutersen. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis (2-oxypropyl) amine-induced pancreatic lesions in hamsters. Cancer Lett. 60:205-211 (1991).
4. S. P. Povoski, W. Zhou, D. S. Longnecker, R. T. Jensen, S. A. Mantey, and R. H. Bell Jr. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by the way of cholecystokinin-A receptors. Gastroenterology 107:1135-1146 (1994).
5. J. R. Wisner, R. E. Mc Laughlin, K. A. Rich, S. Ozawa, and I. G. Renner. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Gastroenterology 94:109-113 (1988).
6. M. Chu, J. F. Rehfeld, and K. Borch. Chronic endogenous hypercholecystokinemia promotes pancreatic carcinogenesis in the hamster. Carcinogenesis 18:315-320 (1997).
7. D. S. Longnecker, B. D. Roebuck, J. D. Yager, H. S. Lilja, and B. Siegmund. Pancreatic carcinoma in azasenne-treated rats: Induction, classification and dietary modulation of incidence. Cancer 47:1562-1572 (1981).
8. A. G. Howatson and D. C. Carter. Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster nitrosamine-model. Br. J. Cancer 51:107-114 (1985).
9. F. E. Johnson, M. C. La Regina, S. A. Martin, and H. M. Bashiti. Cholecystokinin inhibits pancreatic and hepatic carcinogenesis. Cancer Detect. Prev. 6:389-402 (1983).
10. A. Andrén-Sandberg, S. Dawiskiba, and I. Ihse. Studies on the effect of caerulein administration on experimental pancreatic carcinogenesis. Scand. J. Gastroenterol. 19:122-128 (1984).
11. J. P. Smith, T. E. Solomon, S. Bagheri, and S. Kramer. Cholecystokinin stimulates growth of human pancreatic carcinoma SW-1990. Dig. Dis. Sci. 35:1377-1384 (1990).
12. C. M. Townsend Jr, R. B. Franklin, L. C. Watson, E. J. Glass, and J. C. Thompson. Stimulation of pancreatic cancer growth by caerulein and secretin. Surg. Forum 32:228-229 (1981).
13. C. Hudd, M. C. La Regina, J. E. Devine, D. C. Palmer, D. R. Herbold, M. C. Beinfeld, F. B. Gelder, and F. E. Johnson. Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice. Am. J. Surg. 157:386-394 (1989).
14. R. Maani, C. M. Townsend, G. Gomez, J. C. Thompson, and P. Singh. A potent CCK receptor antagonist (L 364,718) inhibits growth of human pancreatic cancer in nude mice [Abstract]. Gastroenterology 94:A274 (1988).
15. B. R. Douglas, R. A. Woutersen, J. B. M. J. Jansen, A. J. L. De Jong, L. C. Rovati, and C. B. H. W. Lamers. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Gastroenterology 96:462-469 (1989).
16. E. F. Lhoste, B. D. Roebuck, and D. S. Longnecker. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY305). Carcinogenesis 9:901-909 (1988).
17. M. Meijers, M. J. Appel, A. van Garderen-Hoetmer, C. B. Lamers, L. C. Rovati, J. B. Jansen, and R. A. Woutersen. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide. Carcinogenesis 13:1525-1528 (1992).
18. T. P. O'Connor, B. D. Roebuck, and T. C. Campbell. Dietary intervention during the postdosing phase of L-azaserine-induced preneoplastic lesions. J. Natl. Cancer Inst. 75:955-957 (1985).
19. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
20. A. Danielsson. Technique for measuring amylase secretion from pieces of mouse pancreas. Anal. Biochem. 59:220-234 (1974).
21. G. M. Richards. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal. Biochem. 57:369-376 (1974).
22. W. C. Schneider. Determination of nucleic acids in tissues by pentose analysis. In: S. P. Colowick and N. O. Kaplan (eds), Methods of enzymology, New York: Academic Press, 1957, pp. 680-684.
23. A. Hajri, C. Bruns, P. Marbach, M. Aprahamian, D. S. Longnecker, and C. Damgé. Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide. Eur. J. Cancer 27:1247-1252 (1991).
24. C. Stock-Damgé, M. Aprahamian, E. Lhoste, J. Marescaux, and E. Loza. Small bowel bypass prevents the trophic action of cholecystokinin on the rat pancreas. Int. J. Pancreatol. 2:257-267 (1987).
25. R. H. Bell Jr, E. T. Kuhlmann, R. T. Jensen, and D. S. Longnecker. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. Cancer Res. 52:3295-3299 (1992).
26. W. Zhou, S. P. Povoski, D. S. Longnecker, and R. H. Bell Jr. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Cancer Res. 52:6905-6911 (1992).
27. J. L. Scemama, D. Fourmy, A. Zahidi, L. Pradayrol, C. Susini, and A. Ribet. Characterization of gastrin receptors on a rat pancreatic acinar cell line (AR4-2J). A possible model for studying gastrin mediated cell growth and proliferation. Gut 28:233-236 (1987).
28. C. Seva, L. De Vries, J. L. Scemama, P. Sarfati, T. G. Nicolet, L. Pradayrol, and N. Vaysse. Gastrin modulates growth of a rat acinar pancreatic cell line: receptor analysis and signal transduction. Digestion 46(suppl 2): 166-169 (1990).
29. S. P. Povoski, W. Zhou, D. S. Longnecker, B. D. Roebuck, and R. H. Bell Jr. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Cancer Res. 53:3925-3929 (1993).
30. B. J. Tsuei, S. P. Povoski, W. Zhou, and R. H. Bell Jr. Gastrin receptor expression during azaserine-induced rat pancreatic carcinogenesis. J. Surg. Res. 63:105-109 (1996).
31. D. H. Yu, S. C. Huang, S. A. Wank, S. Mantey, J. D. Gardner, and R. T. Jensen. Pancreatic receptors for cholecystokinin: evidence for three receptor classes. Am. J. Phvsiol. 258:G86-95 (1990).
32. D. S. Louie, J. P. Liang, and C. Owyang. Characterization of a new CCK antagonist, L 364,718: in vitro and in vivo studies. Am. J. Physiol. 255:G261-266 (1988).